July 16, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Longer-term dual antiplatelet therapy with clopidogrel and aspirin prevented ischemic events without raising bleeding risk in a cohort of Chinese patients with multivessel coronary artery disease who had a stent implant, data showed. In certain populations with high ischemic risk and low bleeding risk, extended DAPT after percutaneous coronary intervention may be a therapeutic option compared
July 16, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

DAPT-MVD tested 2-year DAPT in selected patients with multivessel CAD

Clopidogrel was tested against aspirin in people with coronary artery disease (CAD)

KIAWAH ISLAND, S.C. — Non-stent MIGS devices provided better early IOP reduction and reduced medication use while stent MIGS…

Health system tests multilevel approach for reducing high-risk antiplatelet prescribing

Also in TTHealthWatch: at-home rehab after ICU stay

Since the introduction of durable left ventricular assist devices for advanced heart failure, management of antithrombotic…